Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Current Assets (2020 - 2022)

Historic Current Assets for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $681.9 million.

  • Atea Pharmaceuticals' Current Assets fell 1910.1% to $681.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $681.9 million, marking a year-over-year decrease of 1910.1%. This contributed to the annual value of $772.4 million for FY2021, which is 1054.74% down from last year.
  • Per Atea Pharmaceuticals' latest filing, its Current Assets stood at $681.9 million for Q3 2022, which was down 1910.1% from $689.5 million recorded in Q2 2022.
  • Over the past 5 years, Atea Pharmaceuticals' Current Assets peaked at $871.1 million during Q2 2021, and registered a low of $108.4 million during Q3 2020.
  • In the last 3 years, Atea Pharmaceuticals' Current Assets had a median value of $772.4 million in 2021 and averaged $709.2 million.
  • Per our database at Business Quant, Atea Pharmaceuticals' Current Assets surged by 67753.22% in 2021 and then crashed by 2085.37% in 2022.
  • Over the past 3 years, Atea Pharmaceuticals' Current Assets (Quarter) stood at $863.5 million in 2020, then decreased by 10.55% to $772.4 million in 2021, then dropped by 11.71% to $681.9 million in 2022.
  • Its Current Assets was $681.9 million in Q3 2022, compared to $689.5 million in Q2 2022 and $713.2 million in Q1 2022.